Randomized, phase Ib/II study of M6620 + avelumab + carboplatin vs standard care (sc) in patients (pts) with platinum-sensitive poly (ADP-ribose) polymerase inhibitor-(PARPi)-resistant ovarian cancer Meeting Abstract
| Authors: | Banerjee, S.; Vergotte, I.; Colombo, N.; Barve, M.; Grisham, R.; Mehr, K. T.; Falk, M.; Beier, F.; Hennessy, M.; Schroeder, A.; Birrer, M. |
| Abstract Title: | Randomized, phase Ib/II study of M6620 + avelumab + carboplatin vs standard care (sc) in patients (pts) with platinum-sensitive poly (ADP-ribose) polymerase inhibitor-(PARPi)-resistant ovarian cancer |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz250.068 |
| Language: | English |
| ACCESSION: | WOS:000491295503109 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz250.068 |
| Notes: | Meeting Abstract: 1060TiP -- Appears on pages v431-432 of the abstract book -- Source: Wos |
